Physician profile
Mona K Sood
NPI 1952463358
$2,427.61
in general payments reported to CMS, 2019-2025
16 companies · $595 in 2025
The $595 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2021: $89.39 · 2022: $634 · 2023: $304 · 2024: $332 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $653.49 | 2019-2025 | Myday Contact Lens, Synergeyes Contact Lens |
| Glaukos Corporation | $267.35 | 2022-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Oyster Point Pharma, INC. | $171.63 | 2022 | |
| Bausch & Lomb Americas INC. | $168.62 | 2023-2025 | Infuse |
| Tarsus Pharmaceuticals, INC. | $164.00 | 2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $159.08 | 2019-2022 | |
| Alcon Vision LLC | $142.71 | 2019-2025 | Precision 1, Total30 |
| Avedro INC. | $141.63 | 2019 | |
| Allergan, INC. | $116.01 | 2019 | |
| Biotissue Holdings INC. | $115.08 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $87.08 | 2021-2023 | Acuvue |
| Lkc Technologies, INC. | $79.08 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $74.86 | 2021-2022 | |
| Oculus, INC. | $44.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.28 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.